Carnegie Mellon University »

Neubase Therapeutics shares owned by Carnegie Mellon University

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by Carnegie Mellon University from 13F filings

Historical chart of Carnegie Mellon University investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by Carnegie Mellon University consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by Carnegie Mellon University

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 47k 0.74

More positions owned by Carnegie Mellon University

Duolingo Cl A Com (DUOL)
Carmell Therapeutics Corp - US (CTCX)
Vera Therapeutics Cl A (VERA)
Neubase Therapeutics Com New (NBSE)
Predictive Oncology (POAI)
Innsuites Hospitality Trust Sh Ben Int (IHT)

View all positions for Carnegie Mellon University

Top funds holding Neubase Therapeutics

Greenlight Capital
UBS Group
Point72 Asset Management
Carnegie Mellon University
Two Sigma Investments
Vanguard Group
Kestra Advisory Services
Bank of America Corporation
Royal Bank of Canada
Wells Fargo & Company
Advisor Group Holdings
Pnc Financial Services
Newbridge Financial Services Group
Global Wealth Management Investment Advisory

View all funds holding Neubase Therapeutics